OncoReview
https://journalsmededu.pl/index.php/OncoReview
<p>The main area of <em>OncoReview’s </em> scientific mission is the emerging field of interdisciplinary oncology, with particular emphasis on cardio-oncology. Scientific papers published in the journal concern modern diagnostic and therapeutic methods used in this population of patients, as well as all adverse events related to anticancer treatment. Objective assessment of the benefits and risks of new oncological drugs is a unique benefit of the published works. <br><span lang="en-GB"><br></span><span lang="en-GB"><strong>e-ISSN: </strong>2450-6125 <strong> DOI: </strong>10.24292/01.OR<br><br><strong>Indexed in: </strong></span><strong>SCOPUS</strong>: SJR 2019 = 0.125; SNIP 2019= 0.099<br><span lang="en-GB"> Polish Journals Master List: <strong>20 points</strong> <br> Index Copernicus: 116.25 <br> Google Scholar<br> Polish Medical Bibliography</span></p> <p> </p>
Medical Education sp. z o.o.
en-US
OncoReview
2450-6125
<p><strong>Copyright: © Medical Education sp. z o.o.</strong> This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (<a href="https://creativecommons.org/licenses/by-nc/4.0/">https://creativecommons.org/licenses/by-nc/4.0/</a>), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.</p> <p><em>Address reprint requests to: Medical Education, Marcin Kuźma (<a href="mailto:marcin.kuzma@mededu.pl">marcin.kuzma@mededu.pl</a>)</em></p>
-
Anti-breast cancer potential of honey: A narrative review
https://journalsmededu.pl/index.php/OncoReview/article/view/1744
<p>Cancer is responsible for the death of millions of people all around the world. Among the large group of cancers, the prevalence of breast cancer is highest in women. Therapeutic interventions, including removal surgery, radiation therapy, hormone therapy, and chemotherapy which is largely used, may cause adverse effects on the quality of patients’ life. This fact has encouraged researchers to find natural substances such as honey to overcome harmful effects. Nowadays, honey is recommended for plenty of abnormalities because of its antioxidant, anti-inflammatory, and antimicrobial properties. Various studies have been conducted to explore the anticancer benefits of different types of honey from different origins. In this review, we are going to summarize in-vitro, animal, and human studies on the anti-breast cancer potential of honey.</p>
Mohammad Sadegh Qadirifard
Amirhossein Fathabadi
Hamed Hajishah
Kosar Gholami
Mohammadmehdi Abbasi
Nafiseh Sami
Mostafa Mahmoudi Zo
Fateme Kadkhodaei
Mahla Sina
Arina Ansari
Zahra Rahimi
Niloofar Deravi
Copyright (c) 2022 Medical Education
https://creativecommons.org/licenses/by-nc/4.0
2022-03-31
2022-03-31
12 1(45)
5
15
10.24292/01.OR.121180222
-
Laparoscopic nephron sparing surgery on a patient with extreme body deformation due to cerebral palsy. Is this justified when the tumor biopsy is unavailable?
https://journalsmededu.pl/index.php/OncoReview/article/view/1785
<p>Abdominal surgery on patients with significant body malformation is often a challenge for an operative team. Particularly, when patient presents lesions suspected for malignancy but benign disease cannot be excluded. In the reported case the patient suffered from cerebral palsy and had extreme spinal distortion with significant displacement of internal organs. Solid renal mass was detected incidentally, but because of body deformation the biopsy to asses pathological status could not be performed. The decision to perform surgery was made and the patient underwent successful laparoscopic partial nephrectomy. Pathology examination of the specimen revealed renal cell carcinoma grade 2.</p>
Mirosław Łesiów
Michał Borowik
Robert Liss
Maciej Przudzik
Roman Łesiów
Radosław Grabysa
Maciej Michalak
Marek Roslan
Copyright (c) 2020
http://creativecommons.org/licenses/by-nc-nd/4.0/
2022-03-31
2022-03-31
12 1(45)
16
19
10.24292/01.OR.121310322